CVE-2023-33365: Supremainc Biostar 2

High severity, CVSS 7.5. EPSS: 0.7% chance of exploitation in the next 30 days.

A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.

Affected products

• Supremainc Biostar 2: before 2.9.1 (fixed in 2.9.1)

Published 2023-08-03. Last modified 2026-06-17.